Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Valuck

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Journal of Health Care Finance|April 9, 2005
Consumer responses to a pharmacy benefit report cardKavita V Nair, Robert J Valuck
Journal of Clinical Epidemiology|May 12, 2004
A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adultsRobert J Valuck, J Mark Ruscin
Neuropsychiatric Disease and Treatment|September 8, 2016
The use of the Psychiatric Electroencephalography Evaluation Registry (PEER) to personalize pharmacotherapyDan V Iosifescu, Robert J Neborsky, Robert J Valuck
Archives of General Psychiatry|June 3, 2009
Persisting decline in depression treatment after FDA warningsAnne M Libby, Heather D Orton, Robert J Valuck
The Annals of Pharmacotherapy|April 30, 2002
Vitamin B(12) deficiency associated with histamine(2)-receptor antagonists and a proton-pump inhibitorJ Mark Ruscin, Robert Lee Page, Robert J Valuck
The Journal of Clinical Psychiatry|September 18, 2009
Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case-control studyRobert J Valuck, Heather D Orton, Anne M Libby
Pharmacoepidemiology and Drug Safety|March 5, 2013
Comparative safety of selective serotonin reuptake inhibitors among pediatric users with respect to adverse cardiac eventsAngela S Czaja, Robert J Valuck, Heather D Anderson
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 20, 2007
Evaluation of off-label recombinant activated factor VII for multiple indications in childrenPamela D Reiter, Robert J Valuck, Ruston S Taylor
Pharmacoepidemiology and Drug Safety|August 8, 2015
The depth, duration, and degree of outpatient pediatric polypharmacy in Colorado fee-for-service Medicaid patientsJames A Feinstein, Chris Feudtner, Robert J Valuck, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|December 27, 2011
Thrombosis risk factor assessment and implications for prevention in critically ill childrenPamela D Reiter, Beth Wathen, Robert J Valuck, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Journal of Health Care Finance|April 9, 2005
Consumer responses to a pharmacy benefit report cardKavita V Nair, Robert J Valuck
Journal of Clinical Epidemiology|May 12, 2004
A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adultsRobert J Valuck, J Mark Ruscin
Neuropsychiatric Disease and Treatment|September 8, 2016
The use of the Psychiatric Electroencephalography Evaluation Registry (PEER) to personalize pharmacotherapyDan V Iosifescu, Robert J Neborsky, Robert J Valuck
Archives of General Psychiatry|June 3, 2009
Persisting decline in depression treatment after FDA warningsAnne M Libby, Heather D Orton, Robert J Valuck
The Annals of Pharmacotherapy|April 30, 2002
Vitamin B(12) deficiency associated with histamine(2)-receptor antagonists and a proton-pump inhibitorJ Mark Ruscin, Robert Lee Page, Robert J Valuck
The Journal of Clinical Psychiatry|September 18, 2009
Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case-control studyRobert J Valuck, Heather D Orton, Anne M Libby
Pharmacoepidemiology and Drug Safety|March 5, 2013
Comparative safety of selective serotonin reuptake inhibitors among pediatric users with respect to adverse cardiac eventsAngela S Czaja, Robert J Valuck, Heather D Anderson
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 20, 2007
Evaluation of off-label recombinant activated factor VII for multiple indications in childrenPamela D Reiter, Robert J Valuck, Ruston S Taylor
Pharmacoepidemiology and Drug Safety|August 8, 2015
The depth, duration, and degree of outpatient pediatric polypharmacy in Colorado fee-for-service Medicaid patientsJames A Feinstein, Chris Feudtner, Robert J Valuck, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|December 27, 2011
Thrombosis risk factor assessment and implications for prevention in critically ill childrenPamela D Reiter, Beth Wathen, Robert J Valuck, et al.
Pageof 7